Key result
Severe obesity was associated with impaired arterial smooth muscle function, with lower maximal nitrate-mediated dilatation compared to normal-weight controls (13.4% vs 18.3%, P=0.002).
Why the study?
Does severe obesity impair arterial smooth muscle function (nitrate-mediated dilatation) in young adults compared to normal-weight controls?
Cross-Sectional (n=38)
Does severe obesity impair arterial smooth muscle function (nitrate-mediated dilatation) in young adults compared to normal-weight controls?
Severe obesity in young adults is associated with significantly impaired arterial smooth muscle function, which may contribute to their increased cardiovascular risk.
Impaired nitrate-mediated dilatation in severe obesity signals possible early vascular risk in young adults; hypothesis-generating for longitudinal studies on reversibility.
The degree of arterial dilatation induced by exogenous nitrates (nitrate-mediated dilatation, NMD) has been similar in obese and normal-weight adults after single high-dose glyceryl trinitrate (GTN). We examined whether NMD is impaired in obesity by performing a GTN dose-response study, as this is a potentially more sensitive measure of arterial smooth muscle function. In this cross-sectional study, subjects were 19 obese (age 31.0 ± 1.2 years, 10 male, BMI 44.1 ± 2.1) and 19 age- and sex-matched normal-weight (BMI 22.4 ± 0.4) young adults. Blood pressure (BP), triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein (LDL)-cholesterol, glucose, insulin, high-sensitivity C-reactive protein (hs-CRP), carotid intima-media thickness (CIMT), and flow-mediated dilatation (FMD) were measured. After incremental doses of GTN, brachial artery maximal percent dilatation (maximal NMD) and the area under the dose-response curve (NMD AUC) were calculated. Maximal NMD (13.4 ± 0.9% vs. 18.3 ± 1.1%, P = 0.002) and NMD AUC (54,316 ± 362 vs. 55,613 ± 375, P = 0.018) were lower in obese subjects. The obese had significantly higher hs-CRP, insulin, and CIMT and lower HDL-cholesterol. Significant bivariate associations existed between maximal NMD or NMD AUC and BMI-group (r = -0.492, P = 0.001 or r = -0.383, P = 0.009), hs-CRP (r = -0.419, P = 0.004 or r = -0.351, P = 0.015), and HDL-cholesterol (r = 0.374, P = 0.01 or r = 0.270, P = 0.05). On multivariate analysis, higher BMI-group remained as the only significant determinant of maximal NMD (r² = 0.242, β = -0.492, P = 0.002) and NMD AUC (r² = 0.147, β = -0.383, P = 0.023). In conclusion, arterial smooth muscle function is significantly impaired in the obese. This may be important in their increased cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Ayer et al. (2010) conducted a cross-sectional in Severe Obesity (n=38). Severe obesity vs. Normal-weight was evaluated on Brachial artery maximal percent dilatation (maximal NMD) (p=0.002). Severe obesity was associated with impaired arterial smooth muscle function, with lower maximal nitrate-mediated dilatation compared to normal-weight controls (13.4% vs 18.3%, P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: